https://kuraoncology.com/wp-content/uploads/Fathi_r2_long_thumbnail.png6401137eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2023-09-19 10:54:002023-09-19 10:57:37Dr. Fathi presents the latest KOMET-001 data
https://kuraoncology.com/wp-content/uploads/Mechanism-of-action-for-investigational-menin-inhibitors-including-ziftomenib.jpg235422eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2023-08-08 16:12:302023-08-23 17:07:13Mechanism of action for investigational menin inhibitors, including ziftomenib
https://kuraoncology.com/wp-content/uploads/Video-2-thumbnail.png235422eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2023-06-16 13:47:032023-08-23 17:06:30Can you give a brief overview of unmet medical needs within NPM1-mutated acute myeloid leukemia?